关于附睾-睾丸单元的下降、隐睾症及不育症的预防
On the descent of the epididymo-testicular unit, cryptorchidism, and prevention of infertility.
作者信息
Hadziselimovic Faruk
机构信息
Cryptorchidism Research Institute, Kindermedizinisches Zentrum Liestal, Liestal, Switzerland.
Pediatrics at the University of Basel and Director of Cryptorchidism Research Institfigute, Kindermedizinisches Zentrum, Bahnhofplatz 11, 4410 Liestal, Switzerland.
出版信息
Basic Clin Androl. 2017 Nov 14;27:21. doi: 10.1186/s12610-017-0065-8. eCollection 2017.
This comprehensive review provides in-depth coverage of progress made in understanding the molecular mechanisms underlying cryptorchidism, a frequent pathology first described in about 1786 by John Hunter. The first part focuses on the physiology, embryology, and histology of epididymo-testicular descent. In the last 20 years epididymo-testicular descent has become the victim of schematic drawings with an unjustified rejection of valid histological data. This part also includes discussion on the roles of gonadotropin-releasing hormone, fibroblast growth factors, Müllerian inhibiting substance, androgens, inhibin B, and insulin-like 3 in epididymo-testicular descent. The second part addresses the etiology and histology of cryptorchidism as well as the importance of mini-puberty for normal fertility development. A critical view is presented on current clinical guidelines that recommend early orchidopexy alone as the best possible treatment. Finally, by combining classical physiological information and the output of cutting-edge genomics data into a complete picture the importance of hormonal treatment in preventing cryptorchidism-induced infertility is underscored.
这篇综述全面深入地介绍了在理解隐睾症分子机制方面所取得的进展。隐睾症是一种常见病症,约在1786年由约翰·亨特首次描述。第一部分重点阐述附睾 - 睾丸下降的生理学、胚胎学和组织学。在过去20年里,附睾 - 睾丸下降成为了示意图的牺牲品,合理的组织学数据被无端摒弃。这部分还讨论了促性腺激素释放激素、成纤维细胞生长因子、苗勒管抑制物质、雄激素、抑制素B和胰岛素样3在附睾 - 睾丸下降中的作用。第二部分论述了隐睾症的病因和组织学,以及小青春期对正常生育能力发育的重要性。对当前仅推荐早期睾丸固定术作为最佳治疗方法的临床指南提出了批判性观点。最后,通过将经典生理学信息与前沿基因组学数据的结果整合为一个完整的图景,强调了激素治疗在预防隐睾症所致不育症方面的重要性。